Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphangioleiomyomatosis × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7 cyclopia sequence 6 Prostatic Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Polycystic Ovary Syndrome 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Hematologic Diseases 2 Head and Neck Neoplasms 2 Warts 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Intraepithelial Neoplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Papilloma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Melanoma 1 Male Urogenital Diseases 1 Lymphoma 1 Lymphangioleiomyomatosis 1 Lower Urinary Tract Symptoms 1

Interventions

Sirolimus 4 Sugars 1 Resveratrol 1 Octreotide 1 Loratadine 1 Letrozole 1 Everolimus 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01353209 2024-04-17

TRAIL

University of Cincinnati

Phase 2 Completed

17 enrolled 13 charts

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡